Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation

Background/Aims The safety of direct oral anticoagulants (DOACs) compared with warfarin in patients with both nonvalvular atrial fibrillation (AF) and clinically confirmed liver cirrhosis (LC) has not been well studied. We compared the risk of a major bleeding event between DOAC and warfarin treatme...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Seo Yeon Yoo, Eunju Kim, Gi-Byoung Nam, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Jonggi Choi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Korean Association of Internal Medicine 2022-05-01
Cyfres:The Korean Journal of Internal Medicine
Pynciau:
liver cirrhosis
atrial fibrillation
direct oral anticoagulants
warfarin
Mynediad Ar-lein:http://www.kjim.org/upload/pdf/kjim-2020-622.pdf
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg